Avidia Bancorp CEO Cozzone buys $49,986 in shares
IRVING, Texas - McKesson Corporation (NYSE:MCK) announced Wednesday that its Board of Directors has declared a regular quarterly dividend of 82 cents per share of common stock. This continues the company’s impressive 32-year streak of consistent dividend payments, with 17 consecutive years of dividend increases.
The healthcare services company said in a press release that the dividend will be payable on January 2, 2026, to shareholders of record as of December 1, 2025.
McKesson describes itself as a diversified healthcare services provider that partners with biopharma companies, care providers, pharmacies, manufacturers, and governments to deliver insights, products, and services aimed at making quality care more accessible and affordable.
The company maintains its headquarters in Irving, Texas, and is listed on the New York Stock Exchange.
In other recent news, McKesson has seen several adjustments to its stock price targets by various analyst firms. TD Cowen raised its price target to $864 from $830, maintaining a Buy rating, following McKesson’s Investor Day where the company increased its long-term adjusted earnings per share guidance. UBS also raised its price target to $860 from $820, citing McKesson’s strong cash flow conversion and strategic reinvestment in growth markets. Mizuho adjusted its target to $770 from $750, maintaining a Neutral rating, as McKesson addressed investor concerns by increasing its long-term EPS growth guidance. Leerink Partners increased their price target to $850 from $785, highlighting better-than-expected growth in McKesson’s pharmaceutical segments. However, Jefferies lowered its price target significantly to $84 from $90, despite maintaining a Buy rating, due to concerns over tariff and geopolitical pressures. These developments reflect a mix of optimism and caution among analysts regarding McKesson’s future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.